5,371
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity

ORCID Icon, , , , , , , , & show all
Pages 1-10 | Received 13 Oct 2021, Accepted 29 Nov 2021, Published online: 29 Dec 2021

References

  • Zylke JW, Bauchner H. The unrelenting challenge of obesity. JAMA. 2016;315(21):2277–2278.
  • Cheng Z, Almeida FA. Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link. Cell Cycle. 2014;13(6):890–897.
  • American Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S81–S89.
  • Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364(8):719–729.
  • Ogden CL, Carroll, MD, Curtin, LR, et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303(3):242–249.
  • Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752–1770.
  • Upadhyay J, Farr O, Perakakis N, et al. Obesity as a disease. Med Clin North Am. 2018;102(1):13–33.
  • Yang Y, Fu M, Li MD, et al. O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity. Nat Commun. 2020;11(1):181.
  • Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822–831.
  • Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830.
  • Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094–2101.
  • Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11–22.
  • Huang J, Linares JF, Duran A, et al. NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ. Nat Commun. 2021;12(1):2876.
  • Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93(1):1–21.
  • Barrett T, D.b T, S.e W, et al. Ncbi geo: archive for functional genomics data sets—10 years on. Nucleic Acids Res. 2011;39(Database):1005–1010.
  • Wang J, Zhang C. Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer. Bioengineered. 2021;12(1):898–913.
  • Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high den sity oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185–193.
  • Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
  • Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. the gene ontology consortium. Nat Genet. 2000;25(1):25–29.
  • Kanehisa M. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
  • Saavedra PHV, Huang L, Ghazavi F, et al. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis. Nat Commun. 2018;9(1):4846.
  • Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):607–613.
  • Griffith M, Griffith OL, Coffman AC, et al. DGIdb: mining the druggable genome. Nat Methods. 2013;10(12):1209–1210.
  • Cotto KC, Wagner AH, Feng YY, et al. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 2018;46(D1):D1068–D1073.
  • Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357(4):370–379.
  • Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world–a growing challenge. N Engl J Med. 2007;356(3):213–215.
  • Ahfeldt T, Schinzel RT, Lee YK, et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol. 2012;14(2):209–219.
  • Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19(10):1252–1263.
  • Ebenegger V, Marques-Vidal P, Kriemler S, et al. Differences in aerobic fitness and lifestyle characteristics in pre-schoolers according to their weight status and sports club participation. Obes Facts. 2012;5(1):23–33.
  • Lopes AL, Ap TF, De Souza Campos LG, et al. The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects. Diabetes Metab Syndr Obes. 2013;6:469–475.
  • Ren J, Cheng Y, Ming ZH, et al. Intrauterine hyperglycemia exposure results in intergenerational inheritance via DNA methylation reprogramming on F1 PGCs. Epigenetics Chromatin. 2018;11(1):20.
  • Resh MD. Fyn, a Src family tyrosine kinase. Int J Biochem Cell Biol. 1998;30(11):1159–1162.
  • Bastie CC, Zong H, Xu J, et al. Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. Cell Metab. 2007;5(5):371–381.
  • Mastick CC, Saltiel AR. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem. 1997;272(33):20706–20714.
  • Yamada E, Pessin JE, Kurland IJ, et al. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab. 2010;11(2):113–124.
  • Mkaddem SB, Murua A, Flament H, et al. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat Commun. 2017;8(1):246.
  • Chen Z, Tao Q, Qiao B, et al. Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1. Cancer Manag Res. 2019;11:6043–6059.
  • Berger E, Héraud S, Mojallal A, et al. Pathways commonly dysregulated in mouse and human obese adipose tissue: FAT/CD36 modulates differentiation and lipogenesis. Adipocyte. 2015;4(3):161–180.
  • Yang S, Dai H, Hu W, et al. Association between circulating follistatin-like-1 and metabolic syndrome in middle-aged and old population: a cross-sectional study. Diabetes Metab Res Rev. 2020;37(2):e3373.
  • Münzberg H, Morrison CD. Structure, production and signaling of leptin. Metab Clin Exp. 2015;64(1):13–23.
  • Zhang F, Chen Y, Heiman M, et al. Leptin: structure, function and biology. Vitam Horm. 2005;71:345–372.
  • Rehman K, Akash MSH, Alina Z. Leptin: a new therapeutic target for treatment of diabetes mellitus. J Cell Biochem. 2018;119(7):5016‐5027.
  • Lo KA, Huang S, Walet ACE, et al. Adipocyte long-noncoding RNA transcriptome analysis of obese mice identified Lnc-Leptin, which regulates Leptin. Diabetes. 2018;67(6):1045–1056.
  • Izquierdo AG, Crujeiras AB, Casanueva FF, et al. Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients. 2019;11(11):2704.
  • Szyszka M, Paschke L, Tyczewska M, et al. Analysis of transcriptome, selected intracellular signaling pathways, proliferation and apoptosis of LNCaP cells exposed to high leptin concentrations. Int J Mol Sci. 2019;20(21):5412.
  • Sun P, Zhang Y, Wei Z, et al. Effect of Qing’e Decoction on Leptin/Leptin receptor and bone metabolism in naturally Aging Rats. Evid Based Complement Alternat Med. 2020;2020:2532081.
  • Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256(17):9077–9083.
  • Wilkins HM, Wang X, Menta BW, et al. Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4-carriers. Aging Cell. 2021;20(5):e13356.
  • Gonzalez-Aldaco K, Roman S, Torres-Reyes LA, et al. Association of apolipoprotein e2 Allele with Insulin resistance and risk of type 2 diabetes mellitus among an admixed population of Mexico. Diabetes Metab Syndr Obes. 2020;13:3527–3534.
  • Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–1101.
  • Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544–553.
  • Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013; (1):CD004816. DOI:10.1002/14651858.CD004816.pub5.